Antidiabetic combinations

D2/500 Logo Pill - yellow oval

Generic Name: linagliptin/metformin

Pill with imprint D2/500 Logo is Yellow, Oval and has been identified as Jentadueto linagliptin 2.5 mg / metformin hydrochloride 500 mg. It is supplied by Boehringer Ingelheim Pharmaceuticals, Inc.

Jentadueto is used in the treatment of Diabetes, Type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Jentadueto linagliptin 2.5 mg / metformin hydrochloride 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Jentadueto (Linagliptin and metformin [ lin-a-glip-tin-and-met-for-min ])-D2/500 Logo-linagliptin 2.5 mg / metformin hydrochloride 500 mg-Yellow-Oval
Jentadueto (Linagliptin and metformin [ lin-a-glip-tin-and-met-for-min ])-D2/500 Logo-linagliptin 2.5 mg / metformin hydrochloride 500 mg-Yellow-Oval
Jentadueto (Linagliptin and metformin [ lin-a-glip-tin-and-met-for-min ])-D2/500 Logo-linagliptin 2.5 mg / metformin hydrochloride 500 mg-Yellow-Oval

Jentadueto
Generic Name: linagliptin and metformin [ lin-a-glip-tin-and-met-for-min ]
Imprint: D2/500 Logo
Strength: linagliptin 2.5 mg / metformin hydrochloride 500 mg
Color: Yellow
Size: N/A
Shape: Oval
Availability: Prescription only
Drug Class: Antidiabetic combinations
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00597-0146
Inactive Ingredients:
Latest News
Related Drugs